Piper Sandler & Co’s Patterson-UTI PTEN Stock Holding History

Piper Sandler & Co’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-7,500	Closed	-$190K	–	116
2013 Q4	$190K	Buy	+7,500	New	+$179K	0.16%	78

Other funds holding PTEN

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Piper Sandler & Co's PTEN Position: Q1 2014 in Review

Piper Sandler & Co sold out of Patterson-UTI (PTEN) in Q1 2014, closing a stake of 7,500 shares — an estimated $190K sold.

Piper Sandler & Co first reported a position in PTEN in Q4 2013 and held it in 1 quarter. The position peaked at $190K in Q4 2013. 314 funds tracked by Wall St. Rank hold PTEN as of Q1 2014.

Piper Sandler & Co reported no remaining Patterson-UTI position as of Q1 2014 after selling out during the quarter.
Piper Sandler & Co sold 7,500 Patterson-UTI shares in Q1 2014, an estimated $190K.
Piper Sandler & Co first reported a position in Patterson-UTI in Q4 2013 and held it in 1 quarter.
Piper Sandler & Co's Patterson-UTI position peaked at $190K in Q4 2013.
314 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2014.

Based on Piper Sandler & Co's 13F filing for Q1 2014, filed 15 May 2014.